MIIT's Innovation Task for Biomedical Materials - Greatchina Biomed is the City's Only Selected Entity

CNCB Media News — Changzhou, China (Reporters: Wu Yankeling, Wang Jian)

Recently, the Ministry of Industry and Information Technology (MIIT) released the list of selected entities for the first batch of the "Innovation Task Challenge Program" in the field of biomedical materials. GC Biomedical Technology Co.,Ltd., based in Xinbei District (Changzhou National High-Tech Zone), was successfully selected as the only enterprise from Changzhou to participate in this national initiative.

The Innovation Task Challenge Program aims to accelerate the research, production, and application of biomedical materials by promoting collaboration across the upstream and downstream industries. It seeks to better support the high-quality development of medical devices by identifying and supporting organizations with core technologies and strong innovation capabilities to carry out concentrated R&D efforts. The MIIT will promote the achievements of those enterprises that successfully complete the innovation tasks, while relevant authorities will also provide enhanced support during the medical device registration process.

GC Biomed possesses a professional R&D team specializing in advanced medical device materials. Its core team has long focused on innovation in poly(p-dioxanone) (PPDO) materials for medical applications, with extensive experience in product development and domestic manufacturing. Collaborating with leading domestic research institutions, the company is fully committed to fulfilling this important national R&D mission.